Novavax says its Covid-19 vaccine proved 89.3% effective in UK trial including variant — while South African results slide lower
After playing behind for much of the Covid-19 vaccine race, Novavax has come along with the first efficacy for its protein-based shot, including one of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
